A significant delay to the planned stock market listing of the newly formed chemical giant Borouge Group International (BGI) has been announced, carrying immediate financial implications for investors in Austrian energy group OMV. In a joint statement released Thursday, OMV and its partner, the Abu Dhabi National Oil Company (ADNOC), revealed that the initial public offering (IPO) is now postponed until 2027.
Financial Consequences for Shareholders
This postponement directly affects the anticipated dividend flow from the joint venture. For the 2026 financial year, OMV now expects to receive only $250 million from BGI, a reduction of fifty percent from the previously projected $500 million. Consequently, the distributable income at the OMV parent company level is expected to decrease by between €0.60 and €0.70 per share.
This news arrives as OMV’s share price trades near its yearly peak, having closed at €58.65 on Wednesday, just below a 52-week high set earlier in the week. The stock’s strong annual performance increases the potential for a pullback as investors digest the revised short-term payout outlook.
Should investors sell immediately? Or is it worth buying Omv?
Merger Timeline Remains on Schedule
Despite the capital market setback, the operational merger of the chemical businesses is progressing according to plan. The legal consolidation of Borealis, Borouge, and Nova Chemicals is slated for completion by the end of March. Upon finalization, the entity will become the world’s fourth-largest producer of polyolefins. Ownership will be split evenly between OMV and ADNOC’s subsidiary, XRG. In line with the IPO delay, the exchange offer for remaining minority shareholders in the legacy Borouge unit has also been pushed into the next year.
Long-Term Profitability in Focus
Company management provided medium-term earnings projections to underscore the future entity’s potential. A central component of this growth strategy is the Borouge 4 complex, which is projected to make a significant contribution to profits starting in 2029. Executives forecast a cumulative net profit of $400 million from this facility in its first three years of operation, with an annual growth target of 10 percent thereafter.
While the stretched timeline removes the near-term prospect of a swift special dividend from the transaction, it affords management additional bandwidth to navigate the complex integration of the three merging partners. Provided the operational merger concludes smoothly by the March deadline, the fundamental strength of the new joint venture remains unchanged.
Ad
Omv Stock: Buy or Sell?! New Omv Analysis from March 20 delivers the answer:
The latest Omv figures speak for themselves: Urgent action needed for Omv investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 20.
Omv: Buy or sell? Read more here...
